Health
Sacramento selected as COVID-19 vaccine trial site – KCRA Sacramento
Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
SACRAMENTO, Calif. —Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer.
The trial will span 120 locations with a goal of including 30,000 applicants worldwide.
What we want the community to know is that this is really important research. Its a first step in developing a vaccine for COVID, UC Davis Medical School Dean Allison Brashear said.
UC Davis Me…
-
Noosa News19 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News22 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General18 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland